Professor of Medicine
Department of Medical Oncology
Dana-Farber Cancer Institute and Harvard Medical School
Boston, MA
For groundbreaking contributions to the discovery of the T-cell programmed death-1 receptor (PD-1) signaling pathway and the PD-1 ligands, PD-L1 and PD-L2; for spotlighting the involvement of this pathway in tumor evasion of immunosurveillance; and for demonstrating that blocking this pathway could provoke an antitumor immune response. This quintessential work would ultimately lead to the development of immunotherapies for cancer, autoimmune diseases, and transplant rejection.
The AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology recognizes an active scientist whose outstanding and innovative research has made a major impact on the cancer field and has the potential to stimulate new directions in cancer immunology. To learn more please visit the press release.
View Dr. Freeman’s Fellows of the AACR Academy page.
View Past Recipients.